NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yekaterina ChudnovskyDirector2025-03-053,500,573$5.81
$20.34MBuy
Peter DemuthChief Scientific Officer2024-12-16381$4.41
$1.68kBuy
Jay VenkatesanDirector2024-11-2650,000$0.01
$500.00Buy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky33.95%5,416,212$26.00MInsider
Eisaabc LLC17.18%2,740,978$13.16MInsider
Itzhak Goldberg10.58%1,687,986$8.10MInsider
Victor F. Ganzi6.13%978,698$4.70MInsider
Vanguard Group Inc1.54%245,823$1.18MInstitution
Jay Venkatesan1.13%180,534$866.56kInsider
Gilbert S. Omenn0.50%80,326$385.56kInsider
Geode Capital Management LLC0.44%70,721$339.46kInstitution
Robert Connelly0.29%46,970$225.46kInsider
CM Management LLC0.25%40,000$192.00kInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX2.85%70.59%Net BuyingNet Buying
AVTE67.91%32.09%Net Buying
CRBP46.25%53.75%Net BuyingNet Selling
VERU39.36%33.61%Net SellingNet Buying
SGMT44.49%55.51%Net Selling

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 2.85% institutional shareholders, 70.59% Elicio Therapeutics insiders, and 26.56% retail investors. Yekaterina Chudnovsky is the largest individual Elicio Therapeutics shareholder, owning 5.42M shares representing 33.95% of the company. Yekaterina Chudnovsky's Elicio Therapeutics shares are currently valued at $27.35M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.